I don't know how anyone reads those accounts and thinks " I'm going to buy shares in this company".
They've done well to reduce expenses but that's a one off.
The reversal of impairment costs is the real kicker. It's hard to quantify but this company could be in real trouble if credit losses return to normal.
Ann: HUM 1H21 Interim Financial Statements, page-6
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HUM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
81.5¢ |
Change
-0.015(1.81%) |
Mkt cap ! $400.7M | |||
| Open | High | Low | Value | Volume |
| 81.0¢ | 84.0¢ | 81.0¢ | $174.9K | 212.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2898 | 81.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 83.0¢ | 7249 | 3 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| HUM (ASX) Chart |